{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:28:32Z","timestamp":1765700912421},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/mbc.0000000000000062","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T16:12:20Z","timestamp":1389715940000},"page":"239-245","source":"Crossref","is-referenced-by-count":3,"title":["Study of the fibrinolytic process in a patient with antiphospholipid syndrome"],"prefix":"10.1097","volume":"26","author":[{"given":"Rita","family":"Marchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Garmendia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Kanzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaheli","family":"Fuenmayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl 3","key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0049-3848(11)70011-1","article-title":"Mechanisms of antiphospholipid antibody formation and action.","volume":"127","author":"De Groot","year":"2011","journal-title":"Thromb Res"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1751-553X.2012.01414.x","article-title":"Recent developments in our understanding of the antiphospholipid syndrome.","volume":"34","author":"De Groot","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2007.11.011","article-title":"Autoantibody explosion in antiphospholipid syndrome.","volume":"30","author":"Shoenfeld","year":"2008","journal-title":"J Autoimmun"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2011.04.011","article-title":"New autoantigens in the antiphospholipid syndrome.","volume":"10","author":"Alessandri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1021\/bi960657q","article-title":"Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes.","volume":"35","author":"Willems","year":"1996","journal-title":"Biochemistry"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Antibeta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts.","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.27361","article-title":"Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.","volume":"62","author":"Di Simone","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome.","volume":"12","author":"Krone","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.med.47.1.533","article-title":"The lupus anticoagulantantiphospholipid syndrome.","volume":"47","author":"Shapiro","year":"1996","journal-title":"Annu Rev Med"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-2007-994958","article-title":"The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies.","volume":"25","author":"Ieko","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/0961203302lu178oa","article-title":"Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome.","volume":"11","author":"Erkan","year":"2002","journal-title":"Lupus"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.4049\/jimmunol.167.12.7192","article-title":"Identification of antithrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin.","volume":"167","author":"Hwang","year":"2001","journal-title":"J Immunol"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1160\/TH04-11-0766","article-title":"Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with antithrombin antibody from a patient with antiphospholipid syndrome.","volume":"94","author":"Kolev","year":"2005","journal-title":"Thromb Haemost"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1365-2141.2002.03928.x","article-title":"Suppressed intrinsic fibrinolytic activity by monoclonal antibeta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome.","volume":"119","author":"Takeuchi","year":"2002","journal-title":"Br J Haematol"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2004.07.013","article-title":"Beta2-glycoprotein I, antibeta2-glycoprotein I, and fibrinolysis.","volume":"114","author":"Yasuda","year":"2004","journal-title":"Thromb Res"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1046\/j.1365-2141.2000.01948.x","article-title":"Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome.","volume":"108","author":"Cugno","year":"2000","journal-title":"Br J Haematol"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.4049\/jimmunol.172.9.5765","article-title":"Identification of antiplasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin.","volume":"172","author":"Yang","year":"2004","journal-title":"J Immunol"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0038-1646310","article-title":"Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.","volume":"68","author":"Jurado","year":"1992","journal-title":"Thromb Haemost"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0038-1650552","article-title":"Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies -a crucial role for acquired free protein S deficiency.","volume":"76","author":"Ames","year":"1996","journal-title":"Thromb Haemost"},{"key":"R24-1-20210203","first-page":"69","article-title":"Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome.","volume":"25","author":"Atsumi","year":"1998","journal-title":"J Rheumatol"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.24262","article-title":"Beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation.","volume":"60","author":"Bu","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1073\/pnas.81.12.3640","article-title":"Complete amino acid sequence of human plasma beta 2-glycoprotein I.","volume":"81","author":"Lozier","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.","volume":"116","author":"Agar","year":"2010","journal-title":"Blood"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/bj0510583","article-title":"The determination of plasma fibrinogen by the clot-weight method.","volume":"51","author":"Ingram","year":"1952","journal-title":"Biochem J"},{"key":"R30-1-20210203","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/ATVBAHA.107.153221","article-title":"Heritability of clot formation, morphology, and lysis: the EuroCLOT study.","volume":"27","author":"Carter","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0076-6879(90)82051-3","article-title":"Preparation of polyclonal antibodies.","volume":"182","author":"Dunbar","year":"1990","journal-title":"Methods Enzymol"},{"key":"R32-1-20210203","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0003-2697(87)90587-2","article-title":"Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.","volume":"166","author":"Schagger","year":"1987","journal-title":"Anal Biochem"},{"key":"R33-1-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0049-3848(73)90065-0","article-title":"A modified beta-alanine precipitation procedure to prepare fibrinogen free of antithrombin III and plasminogen.","volume":"3","author":"Jacobsen","year":"1973","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"R34-1-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1538-7836.2007.02504.x","article-title":"Structure of fibrin: impact on clot stability.","volume":"5","author":"Weisel","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R35-1-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/107602960401000201","article-title":"Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia.","volume":"10","author":"Ozturk","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"R36-1-20210203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1568-9972(02)00144-1","article-title":"Antiphospholipid syndrome: pathogenic mechanisms.","volume":"2","author":"Espinosa","year":"2003","journal-title":"Autoimmun Rev"},{"key":"R37-1-20210203","first-page":"366","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms.","volume":"13","author":"Pierangeli","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"R38-1-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/187152508784871963","article-title":"The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.","volume":"6","author":"Weisel","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R39-1-20210203","first-page":"35","article-title":"Effect of antiphospholipid antibodies on the formation and lysis of fibrin network in patients with recurrent miscarriage.","volume":"52","author":"Marchi","year":"2011","journal-title":"Invest Clin"},{"key":"R40-1-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/107602960300900306","article-title":"Increased fibrin polymerization rate in patients with primary antiphospholipid syndrome and systemic lupus erythematosus.","volume":"9","author":"de Pablo","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"R41-1-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","article-title":"Thrombin generation, fibrin clot formation and hemostasis.","volume":"38","author":"Wolberg","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"R42-1-20210203","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1016\/S0021-9258(18)35759-4","article-title":"The effect of fibrin structure on fibrinolysis.","volume":"267","author":"Gabriel","year":"1992","journal-title":"J Biol Chem"},{"key":"R43-1-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/ma60061a009","article-title":"Size and density of fibrin fibers from turbidity.","volume":"11","author":"Carr","year":"1978","journal-title":"Macromolecules"},{"key":"R44-1-20210203","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2003-07-2422","article-title":"Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients.","volume":"103","author":"Cugno","year":"2004","journal-title":"Blood"},{"key":"R45-1-20210203","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1182\/blood-2005-07-2636","article-title":"Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.","volume":"107","author":"Cesarman-Maus","year":"2006","journal-title":"Blood"},{"key":"R46-1-20210203","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)63479-7","article-title":"Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.","volume":"163","author":"Rand","year":"2003","journal-title":"Am J Pathol"},{"key":"R47-1-20210203","first-page":"545","article-title":"The influence of immunoglobulin (IgG) on the assembly of fibrin gels.","volume":"101","author":"Gabriel","year":"1983","journal-title":"J Lab Clin Med"},{"key":"R48-1-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-2143(96)90116-X","article-title":"Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma.","volume":"128","author":"Carr","year":"1996","journal-title":"J Lab Clin Med"},{"key":"R49-1-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0049-3848(91)90109-A","article-title":"Studies on fibrin network structure: the effect of some plasma proteins.","volume":"61","author":"Nair","year":"1991","journal-title":"Thromb Res"},{"key":"R50-1-20210203","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0021-9681(74)90026-5","article-title":"Biologic variation of human serum immunoglobulin concentrations: sex-age specific effects.","volume":"27","author":"Cassidy","year":"1974","journal-title":"J Chronic Dis"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:21:32Z","timestamp":1620958892000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201504000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000062","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}